PT  - JOURNAL ARTICLE
AU  - Briz-Redón, Álvaro
AU  - Belenguer-Sapiña, Carolina
AU  - Serrano-Aroca, Ángel
TI  - A city-level analysis of air pollution, climate and COVID-19 early spread during the Spanish lockdown
AID  - 10.1101/2020.08.09.20171041
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.08.09.20171041
4099  - http://medrxiv.org/content/early/2020/08/13/2020.08.09.20171041.short
4100  - http://medrxiv.org/content/early/2020/08/13/2020.08.09.20171041.full
AB  - The COVID-19 outbreak has escalated into the worse pandemic of the present century. The rapid spread of the new SARS-CoV-2 coronavirus has caused devastating health and economic crises all over the world, with Spain being one of the worst affected countries in terms of confirmed COVID-19 cases and deaths per inhabitant. In this situation, the Spanish Government declared the lockdown of the country with the aim of flattening the epidemic curve. The variations of air pollution in terms of fine particulate matter (PM2.5) levels in 8 cities of Spain are analyzed here considering the effect of meteorology during the COVID-19 lockdown period (from March 15th to April 12th 2020). The results of the analysis show that the 4-week Spanish lockdown was not long enough to reduce the PM2.5 levels in all the cities considered. These reductions were less than those expected, despite the drastically reduced human activity. Furthermore, no associations between COVID-19 accumulated cases and PM2.5 exposure or environmental conditions (temperature, precipitation, wind speed, sunlight hours, maximum pressure) were found during the early spread of the pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors are grateful to the Universitat de Valencia for the VLC-CAMPUS Atraccio de Talent PhD fellowship (awarded to C.B-S) and the Fundacion Universidad Catolica de Valencia San Vicente Martir for the financial support through Grants 2019-231-003UCV and 2020-231-001UCV (awarded to A.S-A).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Details unknownAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data referred to in the manuscript is available under request